改善结核病病例发现的干预措施的成本效益：达成共识以推动投资。
Cost-effectiveness of interventions to improve case finding for tuberculosis: developing consensus to motivate investment.
作者信息
Dowdy David W, Sohn Hojoon
机构信息
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
出版信息
BMC Glob Public Health. 2023 Oct 11;1(1):20. doi: 10.1186/s44263-023-00024-3.
To better evaluate the cost-effectiveness of active case finding for tuberculosis, a framework for estimating long-term cost and impact is needed. We outline such a framework and highlight the need for consensus estimates of which costs to measure; averted morbidity, mortality, and transmission; measurable short-term outcomes; and meaningful cost-effectiveness thresholds.
为了更好地评估结核病主动病例发现的成本效益，需要一个估算长期成本和影响的框架。我们概述了这样一个框架，并强调了就以下方面达成共识估算的必要性：要衡量哪些成本；避免的发病率、死亡率和传播；可衡量的短期结果；以及有意义的成本效益阈值。
Zotero 插件